SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001854270-23-000062
Filing Date
2023-05-09
Accepted
2023-05-09 16:03:58
Documents
14
Period of Report
2023-05-09
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K snti-20230509.htm   iXBRL 8-K 38489
2 EX-99.1 PRESS RELEASE a202305098kex991.htm EX-99.1 59251
6 senti_logoxpra.jpg GRAPHIC 3383
  Complete submission text file 0001854270-23-000062.txt   253823

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT snti-20230509.xsd EX-101.SCH 1902
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT snti-20230509_lab.xml EX-101.LAB 24831
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT snti-20230509_pre.xml EX-101.PRE 13043
8 EXTRACTED XBRL INSTANCE DOCUMENT snti-20230509_htm.xml XML 11294
Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 382-3281
Senti Biosciences, Inc. (Filer) CIK: 0001854270 (see all company filings)

IRS No.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40440 | Film No.: 23901849
SIC: 2836 Biological Products, (No Diagnostic Substances)